GO
Loading...

Enter multiple symbols separated by commas

Search results for "lilly"

REFINE RESULTS

ANY FORMAT

Blog Posts
News
Slideshows
Special Reports
» Video
Wires

Press Releases

SEARCH RESULTS

About 19 results. Sort By: Date | Relevance
Pimco's outlook on the Fed  

Scott Mather, Pimco, provides an outlook on the Fed, a rate hike, and states the Fed prefers "early and gradual" opposed to "late and abrupt."
Source: CNBC.com
Cramer's shopping list for a pullback  

Mad Money's Jim Cramer goes through his list of mine-resistant stocks to see if there are any bargains.
Source: CNBC.com
Health care on a hot streak  

CNBC's Dominic Chu has the update on three health care stocks beating the Street. And the Fast Money traders place their bets on the best health care plays.
Source: CNBC.com
Getting affordable access to cancer drugs: Eli Lilly CEO  

John Lecheiter, Eli Lilly CEO, discusses some of the most promising drugs in stage 3 trials, and gaining affordable drugs for patients.
Source: CNBC.com
Eli Lilly CEO beats Street, raises forecast: CEO  

John Lecheiter, Eli Lilly CEO, weighs in on the company's quarterly results. We did see good top line growth and we are starting to get revenues, says Lecheiter.
Source: CNBC.com
Biogen falls on new data  

The play on Biogen amid new drug data, with Michael Yee, RBC Capital Markets.
Source: CNBC.com
Big Alzheimer's bets  

CNBC's Meg Tirrell reports on the latest developments in Eli Lilly and Biogen's Alzheimer drugs.
Source: CNBC.com
What will be the next success for Alzheimer's?  

CNBC's Meg Tirrell reports big names in biotech as big bets remain on Alzheimer's.
Source: CNBC.com
Big Alzheimer's bets  

CNBC's Meg Tirrell reports on the highly anticipated trial results out from Eli Lilly and Biogen.
Source: CNBC.com
Eli Lilly Alzheimer trial results update  

CNBC's Meg Tirrell reports on the highly-anticipated data on Eli Lilly's new Alzheimer drug.
Source: CNBC.com